Right ventricular myocardial infarction resident survival guide: Difference between revisions
Line 80: | Line 80: | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | |A01= <div style="float: Center; text-align: Center; width: 20em; padding:1em;"> '''Therapuetic Considerations in [[Right Ventriculay Myocardial Infarction]] ( | {{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | |A01= <div style="float: Center; text-align: Center; width: 20em; padding:1em;"> '''Therapuetic Considerations in [[Right Ventriculay Myocardial Infarction]] (RV MI)'''| | | |}} | ||
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | |}} | ||
{{familytree | | | |,|-|-|-|-|v|-|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|-|.| |}} | {{familytree | | | |,|-|-|-|-|v|-|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|-|.| |}} | ||
Line 106: | Line 106: | ||
* [[Milrinone]] | * [[Milrinone]] | ||
* [[Norepinephrine]] | * [[Norepinephrine]] | ||
|C06= <div style="float: Center; text-align: left;"> • '''May be needed in patients with [[cardiogenic shock]] secondary to | |C06= <div style="float: Center; text-align: left;"> • '''May be needed in patients with [[cardiogenic shock]] secondary to RV MI''': | ||
:❑ Direct RV support | :❑ Direct RV support | ||
:❑ Indirect RV support | :❑ Indirect RV support |
Revision as of 18:49, 11 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Mitra Chitsazan, M.D.[2] Mandana Chitsazan, M.D. [3]
Overview
RV infarction is a form of ST elevation myocardial infarction (STEMI) and is characterized by the presence of symptoms of myocardial ischemia associated with persistent ST elevation on electrocardiogram in right-sided lead V4 (V4R), and elevated cardiac enzymes, hypotension, signs of elevated right heart filling pressures (elevated jugular venous pressure) in the absence of signs of elevated left heart filling pressures (clear lung fields). Nitrates, diuretics and beta-blockers should not be administered to the patient with an RV MI.
Causes
Life Threatening Causes
STEMI is a life-threatening condition and must be treated as such irrespective of the underlying cause.
Common Causes
- Plaque rupture
- Aortic dissection with propagation to the right coronary artery
- Cocaine
Diagnosis
Shown below is an algorithm summarizing the diagnosis of Right ventricular myocardial infarction(RVMI) according to the American College of Cardiology and European Society of Cardiology guidelines.
All patients with acute inferior wall myocardial infarction (ST elevation in leads II, III, aVF) | |||||||||||||||||||||||||||||||
Obtain right-sided precordial leads | |||||||||||||||||||||||||||||||
>= 1mm ST elevation in lead V4R | |||||||||||||||||||||||||||||||
Highly suggestive of RVMI | |||||||||||||||||||||||||||||||
Physical examination | Echocardiography | Coronary Angiography | Hemodynamic study | ||||||||||||||||||||||||||||
❑ Classic triad of:
❑ Kussmaul sign
| ❑ RV dilatation | Gold standard diagnostic modality
❑ In the majority of RVMI:
❑ Occasionally:
| ❑ Hemodynamically significant RVMI:
❑ In concomitant LV dysfunction:
❑ Additional hemodynamic changes:
| ||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of Right ventricular myocardial infarction according to the ACC and ESC guidelines.
Therapuetic Considerations in Right Ventriculay Myocardial Infarction (RV MI) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inotropic support | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
• Avoidance of preload-reducing agents, such as:
• In patients with hypotension (without pulmonary congestion): | • In patients with bradyarrhthmias:
• In patients with atrioventricular block:
| • May be needed in patients with cardiogenic shock secondary to RV MI:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Right ventricular myocardial infarction (RVMI) should be ruled out in all patients presenting with acute inferior wall myocardial infarction, in particular in patients with hypotension.
- In patients presenting with chest pain and clinical findings of hypotension, elevated JVP and clear lung fields, consider the differential diagnoses of RVMI. These include:
- Systemic or pulmonary vasodilators may be considered in selected patients to reduce RV afterload, thereby improving cardiac output.
- In patients with severe tricuspid regurgitation due to RVMI, replacement of tricuspid valve or repair of the valve with annuloplasty rings may be considered.
- In patients with RVMI who have unexplained hypoxemia despite administration of 100% oxygen, right-to-left shunting -through a patent foramen ovale or atrial septal defect-, caused by the disproportionate elevation in right-sided filling pressures compared to the normal or slightly increased left-sided filling pressures should be considered.
- Patients with extensive necrosis due to RVMI may be at higher risk of right ventricular perforation during interventional procedures. Right ventricular catheterization or pacemaker insertion should be performed with great care in these patients.
Don'ts
- In patients with RVMI, avoid preload-reducing agents such as nitrates, diuretics, morphine, beta-blockers, and calcium channel blockers.